Terms: = Endocrine gland cancer AND CHD4, Mi2-BETA, 1108, ENSG00000111642, Mi-2b, DKFZp686E06161, Q14839 AND Treatment
12 results:
1. The epigenetic factor chd4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer.
Wang J; Zhong F; Li J; Yue H; Li W; Lu X
J Transl Med; 2023 Jan; 21(1):38. PubMed ID: 36681835
[TBL] [Abstract] [Full Text] [Related]
2. A single-center experience on endoscopic ultrasonography-guided ethanol ablation of insulinomas.
Yan Z; Zhu C; Wu X; Zhu H; Yuan T; Luo Y; Feng Y; Wang Q; Zhang S; Xue H; Zheng Z; Yang A
Pancreatology; 2023 Jan; 23(1):98-104. PubMed ID: 36577553
[TBL] [Abstract] [Full Text] [Related]
3. Reduction of overtreatment without reduction of overdiagnosis in patients with differentiated thyroid cancer: mission impossible.
Oblak T; Perhavec A; Hocevar M; Peric B
Langenbecks Arch Surg; 2021 Sep; 406(6):2011-2017. PubMed ID: 34097134
[TBL] [Abstract] [Full Text] [Related]
4. chd4 Predicts Aggressiveness in PTC Patients and Promotes cancer Stemness and EMT in PTC Cells.
Pratheeshkumar P; Siraj AK; Divya SP; Parvathareddy SK; Alobaisi K; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33419089
[TBL] [Abstract] [Full Text] [Related]
5. High Expression of miR-532-5p, a Tumor Suppressor, Leads to Better Prognosis in Ovarian cancer Both In Vivo and In Vitro.
Wang F; Chang JT; Kao CJ; Huang RS
Mol Cancer Ther; 2016 May; 15(5):1123-31. PubMed ID: 26873729
[TBL] [Abstract] [Full Text] [Related]
6. Pretest prediction and diagnosis of metastatic lesions to the pancreas by endoscopic ultrasound-guided fine needle aspiration.
Krishna SG; Bhattacharya A; Ross WA; Ladha H; Porter K; Bhutani MS; Lee JH
J Gastroenterol Hepatol; 2015 Oct; 30(10):1552-60. PubMed ID: 25867963
[TBL] [Abstract] [Full Text] [Related]
7. Differentiation of pancreatic ductal adenocarcinoma from other neoplastic solid pancreatic lesions: a tertiary oncology center experience.
Krishna SG; Li F; Bhattacharya A; Ladha H; Porter K; Singh A; Ross WA; Bhutani MS; Lee JH
Gastrointest Endosc; 2015 Feb; 81(2):370-9. PubMed ID: 25442085
[TBL] [Abstract] [Full Text] [Related]
8. A systematic comparison of the anti-tumoural activity and toxicity of the three Adv-TKs.
Gao Q; Chen C; Ji T; Wu P; Han Z; Fang H; Li F; Liu Y; Hu W; Gong D; Zhang Z; Wang S; Zhou J; Ma D
PLoS One; 2014; 9(4):e94050. PubMed ID: 24722669
[TBL] [Abstract] [Full Text] [Related]
9. Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome.
De Tommasi C; Vance ML; Okonkwo DO; Diallo A; Laws ER
J Neurosurg; 2005 Nov; 103(5):825-30. PubMed ID: 16304985
[TBL] [Abstract] [Full Text] [Related]
10. Growth in disorders of adrenal hyperfunction.
Savage MO; Scommegna S; Carroll PV; Ho JT; Monson JP; Besser GM; Grossman AB
Horm Res; 2002; 58 Suppl 1():39-43. PubMed ID: 12373013
[TBL] [Abstract] [Full Text] [Related]
11. Hospital discharge of patients with thyroid carcinoma treated with 131I.
Venencia CD; Germanier AG; Bustos SR; Giovannini AA; Wyse EP
J Nucl Med; 2002 Jan; 43(1):61-5. PubMed ID: 11801704
[TBL] [Abstract] [Full Text] [Related]
12. Radiation-induced tumors of the head and neck following childhood irradiation. Prospective studies.
Schneider AB; Shore-Freedman E; Ryo UY; Bekerman C; Favus M; Pinsky S
Medicine (Baltimore); 1985 Jan; 64(1):1-15. PubMed ID: 3965855
[TBL] [Abstract] [Full Text] [Related]
